GOLM1 and fibrosis: In the development cohort, median GP73 and LG2m concentrations were found to be higher in patients with fibrosis/cirrhosis (GP73 121.27 ng/mL; LG2m 29.16 pg/mL) than in healthy controls (GP73 52.99 ng/mL; LG2m 9.01 pg/mL).